Dexmedetomidine Sedation in Children Before MRI Examinations

NACompletedINTERVENTIONAL
Enrollment

1,091

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Deep Sedation
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine is a beneficial sedative for children. It provides a sedation equivalent to a natural deep sleep with negligible respiratory effects. Administration via the nose provides better absorption and faster impact effect. The drug does not taste and does not sting when administered.

Trial Locations (1)

Unknown

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT05163704 - Dexmedetomidine Sedation in Children Before MRI Examinations | Biotech Hunter | Biotech Hunter